Search Results - "Birrell, Michael T."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2

    COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2 by Trubiano, Jason A, Vogrin, Sara, Smibert, Olivia C, Marhoon, Nada, Alexander, Adrian A, Chua, Kyra Y L, James, Fiona L, Jones, Nicholas R L, Grigg, Sam E, Xu, Cecilia L H, Moini, Nasreen, Stanley, Sam R, Birrell, Michael T, Rose, Morgan T, Gordon, Claire L, Kwong, Jason C, Holmes, Natasha E

    Published in PloS one (09-12-2020)
    “…We report on the key clinical predictors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and present a clinical decision rule that…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Potential interventions for an antimicrobial stewardship bundle for Escherichia coli bacteraemia

    Potential interventions for an antimicrobial stewardship bundle for Escherichia coli bacteraemia by Birrell, Michael T., Horne, Kylie, Rogers, Benjamin A.

    “…Escherichia coli is the most commonly identified bacteraemia, and causes a broad spectrum of diseases. The range of clinical conditions associated with E. coli…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Twice daily cefazolin is effective for treatment of serious methicillin-sensitive Staphylococcus aureus infection in an outpatient parenteral antimicrobial therapy program

    Twice daily cefazolin is effective for treatment of serious methicillin-sensitive Staphylococcus aureus infection in an outpatient parenteral antimicrobial therapy program by Birrell, Michael T., Fuller, Andrew

    Published in Therapeutic advances in infectious disease (01-01-2019)
    “…Background: The use of cefazolin for infections caused by Staphylococcus aureus has been demonstrated to be effective, and associated with fewer adverse…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Clinical manifestations of invasive meningococcal disease in Victoria with the emergence of serogroup W and serogroup Y Neisseria meningitidis

    Clinical manifestations of invasive meningococcal disease in Victoria with the emergence of serogroup W and serogroup Y Neisseria meningitidis by Birrell, Michael T., Strachan, Janet, Holmes, Natasha E., Stevens, Kerrie, Howden, Benjamin P., Franklin, Lucinda J., Ivan, Mihaela, Kwong, Jason C.

    Published in Internal medicine journal (01-03-2021)
    “…Background Historically, Australian cases of invasive meningococcal disease (IMD) have been most frequently caused by Neisseria meningitidis serogroup B, but…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Twice daily cefazolin is effective for treatment of serious methicillin-sensitive infection in an outpatient parenteral antimicrobial therapy program

    Twice daily cefazolin is effective for treatment of serious methicillin-sensitive infection in an outpatient parenteral antimicrobial therapy program by Michael T. Birrell, Andrew Fuller

    Published in Therapeutic advances in infectious disease (01-12-2019)
    “…Background: The use of cefazolin for infections caused by Staphylococcus aureus has been demonstrated to be effective, and associated with fewer adverse…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: